| IgAD | GD | SLE | T1D | CD |
---|---|---|---|---|---|
IgAD in patients with | — | 1.6% | 1.3–3.8% | 0.9–1.1% | 2.6% |
GD in patients with | 11.8% | — | 0.5% | 0–24% | 5% |
SLE in patients with | ND | 0.5–2.9% | — | 0.6% | 2.4% |
T1D in patients with | 2.8% | 1.1–15% | 11.6% | — | 5% |
CD in patients with | 7.7–8.7% | 0.9–5.4% | 2.4% | 4–9% | — |